Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05683041

Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
University Hospital, Ghent · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Clinical study on the prevention of intrauterine adhesions after laparoscopic or laparotomic myomectomy. Myomas are common in women of reproductive age and myomectomy can lead to intra-uterine adhesions, which can be detrimental to fertility. This study investigates whether the use of an intrauterine gel can prevent the development of these adhesions.

Detailed description

Design: Double-blind, randomized controlled pilot trial. Participant: * age between 18 and 45 years. * intramurale and/or subserosal myoma (FIGO 3-6), and/or hybrid myoma (with a connection to the endometrium and serosa (FIGO 2-5), who are scheduled for laparoscopic / laparotomic myomectomy. * absence of intra-uterine adhesions on preoperative diagnostic hysteroscopy Treatment: Application of intrauterine Hyalobarrier® gel endo at time of surgery Control: No application of Hyalobarrier® gel endo Follow up: Second-look hysteroscopy after 3months To blind all trial participants and gynaecologists doing second-look hysteroscopy, 10 ml of a sterile ultrasound gel will be applied into the vagina at the end of the procedure in all women regardless of their treatment allocation.

Conditions

Interventions

TypeNameDescription
DEVICEHyalobarrierHyalobarrier is a viscous, transparent gel and is used as a preventive measure for post-operative adhesions in the abdominal and uterine cavity.

Timeline

Start date
2023-02-22
Primary completion
2027-01-01
Completion
2028-01-01
First posted
2023-01-12
Last updated
2025-01-27

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05683041. Inclusion in this directory is not an endorsement.